medigraphic.com
Instituto Nacional de Salud Pública

2005, Number 2

<< Back Next >>

salud publica mex 2005; 47 (2)

Clinical follow up of Mexican women with early onset of breast cancer and mutations in the BRCA1 and BRCA2 genes

Calderón-Garcidueñas AL, Ruiz-Flores P, Cerda-Flores RM, Barrera-Saldaña HA

Language: English
References: 26
Page: 110-115
PDF size: 86.05 Kb.


ABSTRACT

Objective. This study describes the presence of mutations in BRCA1 and BRCA2 genes in a group of Mexican women and the clinical evolution of early onset breast cancer (EOBC). Material and Methods. A prospective hospital based study was performed in a sample of 22 women with EOBC (7 in clinical stage IIA, 8 in IIB, and 7 in IIIA). The patients attended a tertiary care hospital in northeastern Mexico in 1997 and were followed up over a 5-year period. Molecular analysis included: 1) a mutation screening by heteroduplex analysis (HA) of BRCA1 and BRCA2 genes and 2) a sequence analysis. Results. Of 22 patients, 14 (63.6%) showed a variant band detected by heteroduplex analysis of the BRCA1 and BRCA2 genes: 8 polymorphisms, 4 mutations of uncertain significance, and 2 novel truncated protein mutations, one in BRCA1 (exon 11, 3587delT) and the other in the BRCA2 gene (exon 11, 2664InsA). Conclusions. These findings support future studies to determine the significance and impact of the genetic factor in this Mexican women population.


REFERENCES

  1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from cancer in 1990. Int J Cancer 1999;83(1):18-29.

  2. Holford TR, Roush GC, McKay LA. Trends in female breast cancer in Connecticut and the United States. J Clin Epidemiol 1991;44(1):29-39.

  3. Instituto Nacional de Estadística, Geografía e Informática. XII Censo General de Población y Vivienda 2000. Aguascalientes, Aguascalientes: INEGI; 2001. Disponible en: http://www.inegi.gob.mx/est/contenidos/español/temáticos/mediano/anu.asp?t=mpob01

  4. Secretaría de Salud. Compendio del Registro Histopatológico de Neoplasias en México. México, DF: SSA; 1998.

  5. Henderson IC, Patek AJ. Are breast cancers in young women qualitatively distinct? Lancet 1997;349:1488-1489.

  6. Tereschenko IV, Basham VM, Ponder BA, Pharoah PD. BRCA1 and BRCA2 mutations in Russian familial breast cancer. Hum Mutat 2002;19(2):184.

  7. Antoniou AC, Pharoah PD, McMullan G, Day NE, Stratton MR, Peto J et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 2002; 86 (1):76-83.

  8. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16(3):1215.

  9. Ruiz-Flores P, Sinilnikova O, Badzioch M, Calderón-Garcidueñas AL, Chopin S, Fabrice O et al. BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico. Hum Mutat 2002;20(6):474-475.

  10. Cotran R, Kumar V, Robbins S. The breast. En: Schoen F, ed. Patología estructural y funcional. Fifth edition. Madrid: McGraw-Hill- Interamerican; 1998:1201-1222.

  11. Frierson HF Jr, Wolber RA, Berean KW, Franquemont DW, Gaffey MJ, Boyd JC et al. Interobserver reproducibility of the Nottingham modification of the Bloom-Richardson histological grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 1995;103(2):195-198.

  12. Clinton SK. Diet, anthropometry and breast cancer: Integration of experimental and epidemiologic approaches. J Nutr 1997;127 Suppl 5:916S-920S.

  13. Calderón-Garcidueñas AL, Parás-Barrientos FU, Cárdenas-Ibarra L, González-Guerrero JF, Villarreal-Ríos E, Staines-Boone T et al. Risk factors of breast cancer in Mexican women. Salud Publica Mex 2000;42(1):26-33.

  14. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE et al. Assessment and counseling for women with a family history of breast cancer: A guide for clinicians. JAMA 1995;273: 577- 585.

  15. Secretaría de Salud. Subsecretaría de Coordinación y Desarrollo. Encuestas Nacionales de Salud: panorama de la salud en México. México, DF: SSA; 1994.

  16. Gompel C, Kerkem C. The breast. En: Silverberg S. Ed. Principles and practice of surgical pathology. Toronto: Wiley Medical Publications; 1983:245-295.

  17. De León-Matsuda ML, Liede A, Kwan E, Mapua CA, Cutiongco EM Tan A et al. BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines. Int J Cancer 2002;98(4):596-603.

  18. Osorio A, Barroso A, Martínez B, Cebrián A, San Román JM, Lobo F et al. Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Br J Cancer 2000;82(7): 1266-1270.

  19. Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 2001;93(16):1188-1189.

  20. Cerda-Flores RM, Villalobos-Torres MC, Barrera-Saldaña HA, Cortés-Prieto LM, Barajas LO, Rivas F et al. Genetic admixture in three Mexican mestizo populations based on D1S80 and HLA-DQA1 loci. Am J Hum Biol 2002;14(2):257-263.

  21. An Open Access On-Line Breast Cancer Mutation Data Base. An International Collaborative Effort hosted by National Human Genetic Research Institute of the National Institute of Health. The Breast Cancer Information Core database design, structure, and scope. Disponible en: http://www.nhgri.nih.gov/bic/. [2001marzo 14].

  22. Krainer M, Silva-Arrieta S, FitzGerald MG, Shimada A, Ishioka C, Kanamaru R et al. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med 1997;336(20):1416-1421.

  23. Marcus JN, Watson P, Page DL, Lynch HT. Pathology and heredity of breast cancer in younger women. J Natl Cancer Inst Monogr 1994;16:23-34.

  24. Breast Cancer Linkage Consortium. Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 1997;349(9064):1505-1510.

  25. Dejun S, Yanyuan W, Ram C, Jaydutt V. A truncated BRCA1 gene mutation identified in a Hispanic-American breast cancer patient with a family history. Disponible en: www.medicineoftheamericas.org/page_15.html. [2001 abril 3].

  26. Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 1997;277(12):997-1003.




2020     |     www.medigraphic.com